Edition:
United Kingdom

GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

2,432.00INR
5:04am GMT
Change (% chg)

Rs-9.05 (-0.37%)
Prev Close
Rs2,441.05
Open
Rs2,441.00
Day's High
Rs2,444.75
Day's Low
Rs2,425.00
Volume
963
Avg. Vol
9,071
52-wk High
Rs2,798.50
52-wk Low
Rs2,201.20

Chart for

About

GlaxoSmithKline Pharmaceuticals Limited is a pharmaceutical company. The Company and its subsidiary are engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company develops a range of products in approximately three areas, including pharmaceuticals, vaccines and consumer healthcare. The... (more)

Overall

Beta: 0.17
Market Cap(Mil.): Rs204,553.50
Shares Outstanding(Mil.): 84.70
Dividend: 30.00
Yield (%): 1.24

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-Glaxosmithkline Pharmaceuticals ‍appoints Puja Thakur as CFO​

* Says ‍appointed Puja Thakur as whole-time director and CFO​ Source text: http://bit.ly/2gDubM1 Further company coverage:

25 Oct 2017

BRIEF-India's Glaxosmithkline Pharmaceuticals Sept-qtr profit up 32 pct

* Sept quarter profit 1.30 billion rupees versus profit of 988.5 million rupees last year

25 Oct 2017

BRIEF-India's Glaxosmithkline Pharmaceuticals June-qtr profit down about 63 pct

* June quarter profit 264.2 million rupees versus profit of 722.7 million rupees last year

25 Jul 2017

Earnings vs. Estimates